ClinicalTrials.Veeva

Menu

Efficacy and Safety of Potenfill for Temporary Penile Enhancement

Medytox logo

Medytox

Status

Completed

Conditions

Penile Enhancement

Treatments

Device: Potenfill
Device: Powerfill

Study type

Interventional

Funder types

Industry

Identifiers

NCT03512717
MT05-KR17PGE308

Details and patient eligibility

About

The purpose of this study is to evlauate the efficacy and safety of poteinfill, compared to the powerfill.

Enrollment

76 patients

Sex

Male

Ages

19 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Male subjects aged above 19 and below 65. (20≤male≥65)
  2. be rating himself, when screening, as "Small or Very Small" on Self-Questioned Questionnaire ( SQQ) including the question: " How do you rate your penile size? // Very small, Small, Normal, Big, Very Big?"
  3. Subjects will sign an informed consent form

Exclusion criteria

  1. Prior treatment for penile enhancement (e.g. fat, dermal graft).
  2. Subjects who have penile malformation (e.g. Peyronie's disease), which can make impossible to perform the intervention
  3. Allergic to hyalluronic acid.
  4. Inflammatory or/and infectious disease on penis that can affect on this study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

76 participants in 2 patient groups

Potenfill
Experimental group
Treatment:
Device: Potenfill
Powerfill
Active Comparator group
Treatment:
Device: Powerfill

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems